Prestige Brands gets antitrust approval to buy PE-owned Insight: Reuters
Prestige Brands Holdings Inc , which markets and distributes healthcare and cleaning products, has won U.S. antitrust approval to buy Insight Pharmaceuticals Corp on condition that it divest a motion-sickness drug, Reuters reported. In April it was announced that Insight is being sold to Prestige by U.S. private equity firm Swander Pace Capital and Teachers' Private Capital, the investment arm of Ontario Teachers' Pension Plan for US$750 million.
29 August 2014•1 min read
